SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Female Health FHCO
VERU 2.560+0.4%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Glenn Petersen who wrote (66)10/2/2014 12:18:09 PM
From: Savant1 Recommendation

Recommended By
Glenn Petersen

  Read Replies (1) of 211
 
The Female Health Company's Brazilian Distributor, Semina, Awarded Contract For Up To 50 Million FC2 Female Condoms(R)

Oct 02, 2014 08:00:00 (ET)

CHICAGO, Oct. 2, 2014 /PRNewswire/ -- The Female Health Company (NASDAQ-CM: FHCO) today announced that, through its distributor in Brazil, Semina Industria e Comercio Ltda (Semina), it has been awarded an exclusive contract under a public tender to supply up to 50 million FC2 Female Condoms(R) to the Brazilian Ministry of Health. The contract is valid through August 20, 2015, and the Ministry of Health will place orders against this tender at their discretion.

"This contract reflects Brazil's leadership in providing women with options to protect their health and control their reproductive choices," noted Karen King, President and Chief Executive Officer of The Female Health Company. "Brazil has demonstrated true global leadership with its exemplary HIV/AIDS prevention program and a strong commitment to empowering women to take control of their health and wellness."

"This tender process was competitive, and we are pleased that the total value proposition provided by The Female Health Company and its distribution partner, Semina, was recognized by the Brazilian Ministry of Health. We are proud to serve the Brazilian government in offering this important tool for protecting the women of Brazil against sexually transmitted diseases."

Additionally, FHC and Semina have agreed to reinitiate discussions regarding local production of FC2 in Brazil.

About The Female Health Company

The Female Health Company, based in Chicago, Illinois, manufactures and markets the FC2 Female Condom(R) (FC2). Since the Company began distributing FC2 in 2007, it has been shipped to 144 countries. The Company owns certain worldwide rights to the FC2 Female Condom(R), including patents that have been issued in a number of countries around the world. The patents cover the key aspects of FC2, including its overall design and manufacturing process. The FC2 Female Condom(R) is the only currently available female-controlled product approved by FDA that offers dual protection against sexually transmitted infections, including HIV/AIDS, and unintended pregnancy. The World Health Organization (WHO) has cleared FC2 for purchase by U.N. agencies.

About Semina Indústria e Comércio

Semina Industria e Comercio Ltda, based in Sao Paulo, Brazil, is FHC's exclusive distributor of FC2 Female Condoms in Brazil. Semina also manufactures and distributes silicon diaphragms, breastfeeding and other female health products. Semina is also a leading developer and distributor of educational materials focused on reproductive health and family planning. Semina subscribes to the highest international standards of quality and holds certifications of Good Manufacturing Practices and Distribution and its products are duly registered with ANVISA (Brazilian Regulatory Sanitary Agency).

"Safe Harbor" statement
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext